ANDA 77227, held by Sun Pharma Canada. Halobetasol Propionate.
As of Nov 15, 2026, ANDA 77227 (Halobetasol Propionate), held by Sun Pharma Canada, was first approved by FDA on Aug 4, 2005, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 4, 2005 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Halobetasol Propionate0.05% ยท cream;topical | Halobetasol Propionate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
